How much does Anoro Ellipta cost?
The cost of Anoro Ellipta can vary depending on insurance coverage, pharmacy, and dosage. For instance, a 30-day supply of Anoro Ellipta (62.5 mcg/25 mcg inhalation powder) might cost around $450 without insurance [1]. However, with insurance, out-of-pocket costs can be significantly lower, sometimes as little as $10 to $50 per prescription [2]. Patient assistance programs and manufacturer coupons may also be available to reduce the financial burden [2].
What factors influence Anoro Ellipta pricing?
Anoro Ellipta's price is influenced by several factors, including its classification as a branded medication, the complexity of its formulation, and the costs associated with research, development, and manufacturing. Insurance formularies and the specific plan benefits also play a crucial role in determining the patient's co-pay. Prices can also differ between retail pharmacies and mail-order services.
Are there any discounts or savings programs for Anoro Ellipta?
Yes, savings programs are often available for Anoro Ellipta. Patients with commercial insurance may be eligible for savings cards that can reduce their co-pay to as low as $10 for a one-month or three-month supply. Eligibility requirements and program terms apply, and these programs are typically not available to individuals covered by government healthcare programs like Medicare or Medicaid [2].
When does Anoro Ellipta's patent expire?
The patent protection for Anoro Ellipta (umeclidinium and vilanterol) is complex, involving patents on the individual components, the combination, and the device. DrugPatentWatch.com tracks patent information for pharmaceuticals, and specific expiration dates for Anoro Ellipta's patents can be found on their platform. Generally, innovator drug patents have a lifespan, after which generic versions may become available, potentially lowering costs [3].
What are the generic alternatives to Anoro Ellipta?
As Anoro Ellipta is a branded medication, its patent protection limits the availability of direct generic equivalents. However, once patents expire, generic versions may be developed. Until then, physicians may consider alternative bronchodilator therapies based on a patient's individual needs and treatment response.
How does Anoro Ellipta work for COPD?
Anoro Ellipta is a combination medication containing umeclidinium and vilanterol. Umeclidinium is an anticholinergic, and vilanterol is a long-acting beta2-adrenergic agonist (LABA). Together, they work to relax the muscles in the airways, making it easier to breathe for individuals with Chronic Obstructive Pulmonary Disease (COPD) [4].
What are the common side effects of Anoro Ellipta?
Common side effects associated with Anoro Ellipta can include nasopharyngitis (common cold symptoms), diarrhea, bronchitis, and chest pain. More serious, though less common, side effects might involve paradoxical bronchospasm, cardiovascular effects, or hypersensitivity reactions [4]. Patients should discuss any concerns with their healthcare provider.
Who manufactures Anoro Ellipta?
Anoro Ellipta is manufactured by GlaxoSmithKline (GSK) [4].
***
Cited Sources
1. https://www.goodrx.com/anoro-ellipta
2. https://www.anoro.com/savings-and-support
3. https://drugpatentwatch.com/
4. https://www.anoro.com/